GWPH

Wednesday March 12, 2014, Today Stock Market …

NEW! Download all of 2013 Performance: Click to Download!OR Download all of 2014 Performance to Date: Click to Download!Dow opens – 62 and we are in a sea of red.Market Open (click to enlarge)The Dow closes – 11  This is what we closed out:BITA – 3642, CLNE -4050, GWPH – 3577, IMOS -2362, LVLT -210, MEG -2025, RDN -1365, PRTA […]

Tuesday March 11, 2014, Today Stock Market …

NEW! Download all of 2013 Performance: Click to Download!OR Download all of 2014 Performance to Date: Click to Download!Dow opens – 1 and our open trade jumps to nearly 12k.Market Open (click to enlarge)GWPH (click image to enlarge)TSLA (click image to enlarge)BITA (click image to enlarge)LVLT  (click image to enlarge)The Dow closes – 67  This is what we closed out:ABTL […]

Wednesday March 5, 2014, Today Stock Market …

NEW! Download all of 2013 Performance: Click to Download!OR Download all of 2014 Performance to Date: Click to Download!Dow opens – 20 and our open trade improves slightly.Market Open (click to enlarge)SFUN (click image to enlarge)GWPH (click image to enlarge)INVN (click image to enlarge)BITA (click image to enlarge)NG (click image to enlarge)The Dow closes -35  This is what we closed […]

GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex® in the Treatment of Lennox-Gastaut Syndrome

[at noodls] – 28 February 2014 London, UK; 28 February 2014: GW Pharmaceuticals plc (AIM: GWP, Nasdaq: GWPH, GW) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation … moreView todays social media effects on GWPHView the latest stocks trending across Twitter. Click to view dashboardSee who GW is hiring next, click here to […]

GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome

[GlobeNewswire] – LONDON — GW Pharmaceuticals plc (AIM:GWP) (GW) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Epidiolex(R), GW’s product candidate … moreView todays social media effects on GWPHView the latest stocks trending across Twitter. Click to view dashboardSee who GW is hiring next, click here to view […]